Preoperative supplementation with fibrinogen concentrate in cardiac surgery: A randomized controlled study
- PMID: 26577034
- DOI: 10.1093/bja/aev367
Preoperative supplementation with fibrinogen concentrate in cardiac surgery: A randomized controlled study
Abstract
Background: Bleeding remains a severe complication in cardiac surgery. Several studies have found an association between the preoperative plasma concentration of fibrinogen and postoperative bleeding in cardiac surgery patients. This raises the question of whether preoperative supplementation with fibrinogen concentrate can reduce postoperative blood loss.
Methods: An investigator-initiated, prospective, randomized double-blind placebo-controlled study, was performed in 48 low-risk, coronary artery bypass grafting patients. Subjects were randomized to infusion of 2 g fibrinogen or placebo immediately before surgery, after induction of anaesthesia. The primary endpoint was blood loss during the first 12 h postoperatively. Secondary endpoints included the proportion of transfused subjects, the number of transfused allogeneic blood products (red blood cells, plasma and platelets), and haemoglobin concentration after surgery. Student's t-test and Mann-Whitney U-test was used to compare continuous data and χ(2)-test to compare categorical data between groups.
Results: Median postoperative bleeding was not significantly different between the fibrinogen and placebo groups [650 (25/75th percentile 500‒835) ml compared with 730 (543‒980) ml, P=0.29]. The proportion of transfused subjects (33 vs 29%, P=0.76), number of perioperative transfusions of allogeneic blood products (0 (0-2 vs 0 (0-3), P=0.76) and haemoglobin concentration 24 h after surgery (107 (sd 11) vs 100 (12) g L-1, P=0.07) were not significantly different between the fibrinogen and placebo group, respectively.
Conclusion: Preoperative supplementation with 2 g fibrinogen concentrate did not significantly influence postoperative bleeding, in coronary artery bypass grafting patients without documented hypofibrinogenaemia.
Clinical trial registration: NCT 00968045.
Trial registration: ClinicalTrials.gov NCT00968045.
Keywords: cardiac surgery; fibrinogen; haemorrhage.
© The Author 2015. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Comment in
-
Preoperative supplementation with fibrinogen concentrate in cardiac surgery.Br J Anaesth. 2017 Feb;118(2):272-273. doi: 10.1093/bja/aew451. Br J Anaesth. 2017. PMID: 28100537 No abstract available.
Similar articles
-
Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.J Am Heart Assoc. 2015 Jun 2;4(6):e002066. doi: 10.1161/JAHA.115.002066. J Am Heart Assoc. 2015. PMID: 26037084 Free PMC article. Clinical Trial.
-
The effect of fibrinogen concentrate on perioperative bleeding in transurethral resection of the prostate: a double-blind placebo-controlled and randomized study.J Thromb Haemost. 2017 Feb;15(2):255-262. doi: 10.1111/jth.13575. Epub 2017 Feb 1. J Thromb Haemost. 2017. PMID: 27888575 Clinical Trial.
-
Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial.JAMA. 2017 Feb 21;317(7):738-747. doi: 10.1001/jama.2016.21037. JAMA. 2017. PMID: 28241354 Clinical Trial.
-
Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery.Thromb Res. 2011;128 Suppl 1:S17-9. doi: 10.1016/S0049-3848(12)70005-1. Thromb Res. 2011. PMID: 22221846 Review.
-
Pre-operative fibrinogen supplementation in cardiac surgery patients: an evaluation of different trigger values.Acta Anaesthesiol Scand. 2015 Apr;59(4):427-33. doi: 10.1111/aas.12469. Epub 2015 Jan 20. Acta Anaesthesiol Scand. 2015. PMID: 25600583 Review.
Cited by
-
Fibrinogen: the higher the better?Blood Transfus. 2025 Jan;23(1):79-82. doi: 10.2450/BloodTransfus.978. Blood Transfus. 2025. PMID: 39977523 Free PMC article. No abstract available.
-
A Low-dose human fibrinogen is not effective in decreasing postoperative bleeding and transfusion requirements during cardiac surgery in case of concomitant clinical bleeding and low FIBTEM values: A retrospective matched study.Ann Card Anaesth. 2018 Jul-Sep;21(3):262-269. doi: 10.4103/aca.ACA_145_17. Ann Card Anaesth. 2018. PMID: 30052212 Free PMC article.
-
Long-Term Safety Analysis of a Fibrinogen Concentrate (RiaSTAP®/Haemocomplettan® P).Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241254106. doi: 10.1177/10760296241254106. Clin Appl Thromb Hemost. 2024. PMID: 38803191 Free PMC article. Review.
-
Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.Cochrane Database Syst Rev. 2018 Dec 24;12(12):CD010649. doi: 10.1002/14651858.CD010649.pub2. Cochrane Database Syst Rev. 2018. PMID: 30582172 Free PMC article.
-
Perioperative Changes in Hemostatic Properties as Assessed by Multiplate, Siemens PFA-200, and ROTEM-A Comparative Study.J Clin Med. 2025 Feb 28;14(5):1640. doi: 10.3390/jcm14051640. J Clin Med. 2025. PMID: 40095585 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical